Institute of Immunology and Immunotherapy Immunology is at the forefront of medical research and we are among the leaders of this exciting, fast-evolving field.
News NIHR awards £4m to the Birmingham NIHR Clinical Research Facility to enhance research delivery The funding will pay for new research equipment and improve research facilities for patients across the NHS.
News Birmingham Biomedical Research Centre at the University Hospitals Birmingham Research Showcase 2023
QS World University Subject Rankings released for 2023 University of Birmingham rises 30 places to be joint 62nd in the world for Life Sciences and Medicine.
03 February 2023 Immunocompromised patients remain at higher risk of COVID-19 death in hospital Patients had 44% higher risk of death in hospital compared to those with healthy immune system function
16 January 2023 Experimental cancer therapy research continues at Birmingham New and innovative ways to detect and treat cancer being trialled at Birmingham are to receive renewed funding from Cancer Research UK and the NIHR.
08 December 2022 MDS colleagues celebrate receiving MRC clinical fellowships Two University of Birmingham researchers have been awarded prestigious Medical Research Council (MRC) clinical fellowships this year.
01 December 2022 Immune T cell defence is coping with COVID-19 variants of concern – for now Broad T-cell response is currently protective but recognition of seven out of ten T-cell targets mutated in SARS-CoV-2 variants is impaired
14 November 2022 New UK-first trial to screen 20,000 children for type 1 diabetes Blood tests will identify children likely to develop type 1 diabetes, allowing earlier, safer diagnosis
10 November 2022 Early career researcher acknowledged for work to better understand thymus function The International Eosinophil Society announces University of Birmingham researcher as a winner of the Gerald J. Gleich Award 2022.
08 November 2022 Antibody therapies against Covid-19 for most vulnerable patients work, new analysis finds The largest analysis of data on antibody therapies for protecting clinically extremely vulnerable people from Covid-19 shows that they are effective.